Skip to ContentSkip to Navigation
How to find us prof. dr. E. (Edwin) Bremer


Harnessing the soil: reshaping the tumor microenvironment towards an antitumor immune state by low-dose metformin

High Loading Efficiency and Controlled Release of Bioactive Immunotherapeutic Proteins Using Vaterite Nanoparticles

Inhibition of Autophagy Does Not Re-Sensitize Acute Myeloid Leukemia Cells Resistant to Cytarabine

The Role of Macrophages in Cancer Development and Therapy

Whispering Gallery Modes-based biosensors for real-time monitoring and binding characterization of antibody-based cancer immunotherapeutics

Low-dose metformin reprograms the tumor immune microenvironment in human esophageal cancer: Results of a phase II clinical trial

The Neutrophil: The Underdog That Packs a Punch in the Fight against Cancer

Bispecific Antibody Approach for Improved Melanoma-Selective PD-L1 Immune Checkpoint Blockade

Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis

CD47 Expression Defines Efficacy of Rituximab with CHOP in Non-Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL

Read more